Position in LH
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$61,244,680
+$8,001,678 QoQ
Shares Held
218,731
+9.6% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#61
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JOHNSON INVESTMENT COUNSEL INC holds $199,150,782 across 8 Diagnostics & Research names. LH ranks #2 (30.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
653,183 | $124,418,297 | |
| 2 | LH |
Labcorp Holdings Inc.
This page
|
218,731 | $61,244,680 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
18,789 | $4,261,157 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
5,866 | $2,940,977 | |
| 5 | DGX |
Quest Diagnostics Inc
|
12,820 | $2,717,199 | |
| 6 | QGEN |
Qiagen N.V.
|
56,506 | $2,209,384 | |
| 7 | WAT |
Waters Corp /De/
|
2,473 | $927,473 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
815 | $431,615 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,244,680 | 218,731 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $53,243,002 | 199,554 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $253,890 | 1,012 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $287,347 | 1,001 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $262,772 | 1,001 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $232,740 | 1,000 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $278,853 | 1,216 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $271,528 | 1,215 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $246,654 | 1,212 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||